Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | BAX | Q07812 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8528998 | 0.81 | SMN1; SMN2 (0.44) | TSHRHTTSMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL983817 | 0.79 | LTA4H (0.38) | LTA4HTSHRHTTSMN1; SMN2LMNA | |
| SCHEMBL982444 | 0.78 | LTA4H (0.42) | LTA4HTSHRHTTSMN1; SMN2NR1H2 | |
| SCHEMBL8192888 | 0.78 | LTA4H (0.49) | LTA4HTSHRSMN1; SMN2CYP1A2CYP2C19 | |
| SCHEMBL6295274 | 0.77 | LTA4H (0.41) | LTA4HTSHRHTTSMN1; SMN2NR1H2 | |
| SCHEMBL983863 | 0.76 | LTA4H (0.38) | LTA4HTSHRALDH1A1KDM4EHPGD | |
| SCHEMBL982120 | 0.75 | LTA4H (0.44) | LTA4HTSHRHTTLMNAALDH1A1 | |
| SCHEMBL984172 | 0.74 | LTA4H (0.44) | LTA4HHTTSMN1; SMN2MAOALMNA | |
| SCHEMBL7885832 | 0.73 | LTA4H (0.41) | LTA4HTSHRHTTLMNAALDH1A1 | |
| SCHEMBL8129833 | 0.73 | LTA4H (0.37) | LTA4HTSHRHTTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-9233918-B2 | Isocyanate production process | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-2275406-A1 | PROCESS FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-6914119-B2 | Heat-resistant polyether, curable polyether, and coating liquid for forming a polyether film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-05 | — | — | US | disclosed |
| US-20030060591-A1 | Heat-resistant polyether, curable polyether, and coating liquid for forming a polyether film | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-03-27 | — | — | US | disclosed |
| US-6175025-B1 | Process for synthesizing metallocene compounds | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-1028945-A1 | SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | Amgen Inc. (US) | 2000-08-23 | — | — | EP | disclosed |
| WO-1999024404-A1 | SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | AMGEN INC. (US) | 1999-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | CPS1, PHGDH, APEH | LTA4H 1039/4885TSHR 4853/4885HTT 2433/4885 |
| US-20030060591-A1 | Heat-resistant polyether, curable polyether, and coating liquid for forming a polyether film | HEATR1, HSP90AA1, HEATR6 | LTA4H 3689/4885TSHR 1935/4885HTT 1575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.